Table of Contents
ISRN Organic Chemistry
Volume 2013, Article ID 587054, 7 pages
http://dx.doi.org/10.1155/2013/587054
Research Article

Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3-a]quinoxaline Derivatives as Novel Anticonvulsant Agents

Faculty of Pharmacy, Organic Chemistry Department, Al-Azhar University, Cairo 11884, Egypt

Received 26 June 2013; Accepted 13 August 2013

Academic Editors: A. Hajra, R. Pohl, and F. L. Van Delft

Copyright © 2013 Mohamed Alswah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Erez, H. Frenk, O. Goldberg, A. Cohen, I. Vivian, and V. I. Teichberg, “Anticonvulsant properties of 3-hydroxy-2-quinoxalinecarboxylicacid, a newly found antagonist of excitatory amino acids,” European Journal of Pharmacology, vol. 110, pp. 31–39, 1985. View at Google Scholar
  2. J. Ohmori, S. Sakamoto, H. Kubota et al., “6-(1H-imidazol-1-yl)-7-nitro-2,3 (1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA- type non-NMDA receptor,” Journal of Medicinal Chemistry, vol. 37, no. 4, pp. 467–475, 1994. View at Google Scholar · View at Scopus
  3. G. De Sarro, R. Gitto, E. Russo et al., “AMPA receptor antagonists as potential anticonvulsant drugs,” Current Topics in Medicinal Chemistry, vol. 5, no. 1, pp. 31–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Olayiwola, C. A. Obafemi, and F. O. Taiwo, “Synthesis and neuropharmacological activity of some quinoxalinone derivatives,” African Journal of Biotechnology, vol. 6, no. 6, pp. 777–786, 2007. View at Google Scholar · View at Scopus
  5. M. M. Ali, M. M. F. Ismail, M. S. A. El-Gaby, M. A. Zahran, and Y. A. Ammar, “Synthesis and antimicrobial activities of some novel quinoxalinone derivatives,” Molecules, vol. 5, no. 6, pp. 864–873, 2000. View at Google Scholar · View at Scopus
  6. M. M. Badran, A. A. Moneer, H. M. Refaat, and A. A. El-Malah, “Synthesis and antimicrobial activity of novel quinoxaline derivatives,” Journal of the Chinese Chemical Society, vol. 54, no. 2, pp. 469–478, 2007. View at Google Scholar · View at Scopus
  7. J.-P. Kleim, R. Bender, U.-M. Billhardt et al., “Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication,” Antimicrobial Agents and Chemotherapy, vol. 37, no. 8, pp. 1659–1664, 1993. View at Google Scholar · View at Scopus
  8. B. Zarranz, A. Jaso, I. Aldana, and A. Monge, “Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives,” Bioorganic and Medicinal Chemistry, vol. 11, no. 10, pp. 2149–2156, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Guillon, I. Forfar, M. Mamani-Matsuda et al., “Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents,” Bioorganic and Medicinal Chemistry, vol. 15, no. 1, pp. 194–210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Abid and A. Azam, “Synthesis, characterization and antiamoebic activity of 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazoline derivatives,” Bioorganic & Medicinal Chemistry Letters, vol. 16, no. 10, pp. 2812–2816, 2006. View at Google Scholar
  11. A. A. Abu-Hashem, M. A. Gouda, and F. A. Badria, “Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents,” European Journal of Medicinal Chemistry, vol. 45, no. 5, pp. 1976–1981, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. I. R. Ager, A. C. Barnes, G. W. Danswan et al., “Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles,” Journal of Medicinal Chemistry, vol. 31, no. 6, pp. 1098–1115, 1988. View at Google Scholar · View at Scopus
  13. B. Solano, V. Junnotula, A. Marín et al., “Synthesis and biological evaluation of new 2-arylcarbonyl-3- trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues,” Journal of Medicinal Chemistry, vol. 50, no. 22, pp. 5485–5492, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Teng, M. D. Johnson, C. Thomas et al., “Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 19, pp. 5472–5478, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Y. Hassan, S. N. Khattab, A. A. Bekhit, and A. Amer, “Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase a inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 6, pp. 1753–1756, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. F. M. Atta and E. S. H. El Ashry, “Synthesis of 4-(1-phenyl-1H-pyrazol-3-yl)-[1,2,4]triazolo[4,3-a] quinoxalines and their 4-halogenopyrazolyl analogs,” Journal of Heterocyclic Chemistry, vol. 48, no. 5, pp. 1216–1223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. R. Myers, W. He, B. Hanney et al., “Potent quinoxaline-based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR exploration and effective bioisosteric replacement of a phenyl substituent,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 18, pp. 3091–3095, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Szabó, R. Kiss, D. Páyer-Lengyel et al., “Hit-to-lead optimization of pyrrolo[1,2-a]quinoxalines as novel cannabinoid type 1 receptor antagonists,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 13, pp. 3471–3475, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Almasirad, S. A. Tabatabai, M. Faizi et al., “Synthesis and anticonvulsant activity of new 2-substituted-5-[2-(2- fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 24, pp. 6057–6059, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Bicking, “Bicyclic-nitrogen-heterocyclic-compounds,” Chemical Abstracts, vol. 54, p. 8854, 1960. View at Google Scholar
  21. S. Wagle, A. V. Adhikari, and N. S. Kumari, “Synthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted-4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsants,” European Journal of Medicinal Chemistry, vol. 44, no. 3, pp. 1135–1143, 2009. View at Google Scholar
  22. D. R. Romer, “Synthesis of 2,3-dichloroquinoxalines via vilsmeier reagent chlorination,” Journal of Heterocyclic Chemistry, vol. 46, no. 2, pp. 317–319, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Sarges, H. R. Howard, R. G. Browne, L. A. Lebel, P. A. Seymour, and B. K. Koe, “4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants,” Journal of Medicinal Chemistry, vol. 33, no. 8, pp. 2240–2254, 1990. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Könnecke, R. Dörre, and E. Lippmann, “Synthesen mit Tetrazolo[1,5-a]chinoxalinen,” Zeitschrift Für Chemie, vol. 18, no. 7, pp. 257–258, 1978. View at Google Scholar
  25. M. K. El-Said, S. M. E. Aly, F. A. Romeih, F. F. Barsoum, and A. B. Hassan, “Synthesis and pharmacological testing of some new phenothiazine derivatives,” Egyptian Journal of Pharmaceutical Sciences, vol. 32, pp. 251–261, 1991. View at Google Scholar
  26. B. S. Furniss, A. J. Hannaford, P. W. G. Smith, and A. R. Tatchell, VOGEL'S Textbook of Practical Organic Chemistry, 5th edition, 1989.